Page last updated: 2024-10-31

metoclopramide and Plasma Cell Tumor

metoclopramide has been researched along with Plasma Cell Tumor in 1 studies

Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.

Research Excerpts

ExcerptRelevanceReference
"A patient with myeloma nephropathy and acute, probably diclofenac-induced renal failure developed a neuroleptic malignant syndrome (NMS) during treatment with metoclopramide and neuroleptics."7.68[Malignant neuroleptic syndrome under metoclopramide and neuroleptics in anuria]. ( Herren, T; Krähenbühl, S; Raisin, J, 1993)
"A patient with myeloma nephropathy and acute, probably diclofenac-induced renal failure developed a neuroleptic malignant syndrome (NMS) during treatment with metoclopramide and neuroleptics."3.68[Malignant neuroleptic syndrome under metoclopramide and neuroleptics in anuria]. ( Herren, T; Krähenbühl, S; Raisin, J, 1993)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Krähenbühl, S1
Raisin, J1
Herren, T1

Other Studies

1 other study available for metoclopramide and Plasma Cell Tumor

ArticleYear
[Malignant neuroleptic syndrome under metoclopramide and neuroleptics in anuria].
    Schweizerische medizinische Wochenschrift, 1993, Jul-03, Volume: 123, Issue:26

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Anuria; Chlorpromazine; Female; Humans; Kidney

1993